Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.95 – $6.10
94% from low
No one on the platform currently holds NGENF.
No tracked institution reports a position in NGENF as of their last filing.
No one on the platform has traded NGENF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-0.30 | $-0.30–$-0.30 | — | 1 |
| 2027 | $0 | — | $-0.26 | $-0.26–$-0.26 | — | 1 |
| 2028 | $0 | — | $0.01 | $0.01–$0.01 | 569.8× | 1 |
| 2029 | $0 | — | $2.10 | $2.10–$2.10 | 2.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-11-24 | $-0.06 | $-0.04 | +33.3% |
| 2025-08-28 | $-0.06 | $-0.09 | -68.6% |
| 2025-05-14 | $-0.06 | $-0.04 | +33.6% |
| 2024-11-14 | $-0.05 | $-0.05 | -6.2% |
| 2024-08-22 | $-0.07 | $-0.08 | -24.4% |
| 2024-05-16 | $-0.05 | $-0.03 | +45.6% |
| $799M |
| — |
| IPHYFInnate Pharma S.A. | $1.65 | +0.00% | $155M | — |
| JWCTFJW (Cayman) Therapeutics Co. Ltd | $0.20 | +0.00% | $84M | — |
Source: Financial Modeling Prep · peers by sector/industry